Horizon Pharma (Nasdaq: HZNP) will pay a premium of approximately $1.1 billion in cash to buy Hyperion Therapeutics Inc. (Nasdaq: HPTX). Shares of Horizon soared $3.28 to $25.09 while Hyperion stock climbed $3.36 to $46.10.